Rosacea treatments: What's new and what's on the horizon?

American Journal of Clinical Dermatology
Rosella GalloAurora Parodi

Abstract

Rosacea is a common, chronic, cutaneous disorder presenting with recurrent episodes of facial flushing, erythema, papules, pustules and telangiectasias. It is a multifactorial disease and its various clinical presentations probably represent the consequence of combined different triggers upon a specific background. Its management is largely based on long-established treatments empirically tailored to the specific presenting symptoms and no real breakthrough has occurred to date. However, recent insights into the still rather obscure pathophysiology of rosacea seem to open the way for etiologically oriented treatments. These may include, on the one side, the more effective application of traditional drugs, such as tetracyclines and metronidazole, to specifically selected patients or, on the other side, new therapeutic options, such as vitamin D receptor antagonists. It is to be remarked that the quality of most studies evaluating rosacea treatment is rather poor, mainly due to a lack of proper standardization. For a major breakthrough to occur in the management of rosacea, we need both a better understanding of its pathogenesis and the adherence of future clinical trials to clearly defined grading and inclusion criteria, which a...Continue Reading

References

Apr 8, 1967·Lancet·R MarksW B Robertson
Mar 1, 1993·Journal of the American Academy of Dermatology·E BonnarF C Powell
Jan 1, 1995·Dermatology : International Journal for Clinical and Investigative Dermatology·A ReboraA Parodi
Aug 16, 2002·American Journal of Clinical Dermatology·Alfredo Rebora
Apr 4, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·Claudine Piérard-FranchimontGérald E Piérard
Jun 6, 2003·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Kenneth A MarkDeborah S Sarnoff
Aug 21, 2003·Acta Dermato-venereologica·Camilo DiazAndrew Ilchyshyn
Jan 17, 2004·Journal of the American Academy of Dermatology·Mark V DahlPatrick M Schlievert
May 22, 2004·Journal of the American Academy of Dermatology·Jonathan WilkinUNKNOWN National Rosacea Society Expert Committee
Aug 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tian-Tian WangJohn H Hanrahan
Feb 25, 2005·The New England Journal of Medicine·Frank C Powell
Jan 25, 2006·Investigative Ophthalmology & Visual Science·Sergio Claudio SaccàAlfredo Rebora
Dec 28, 2006·Journal of the American Academy of Dermatology·Esther J van ZuurenSally Hollis
Feb 23, 2007·Drugs of Today·Brian BermanDeborah Zell
Jun 29, 2007·The British Journal of Dermatology·N LaceyF C Powell
Aug 7, 2007·Nature Medicine·Kenshi YamasakiRichard L Gallo
Mar 14, 2008·The Journal of Investigative Dermatology·Siegfried Segaert
Apr 29, 2008·The Journal of Allergy and Clinical Immunology·Jürgen Schauber, Richard L Gallo
May 6, 2008·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Andrea ParodiVincenzo Savarino
Jun 21, 2008·The British Journal of Dermatology·P PapageorgiouM Rustin
Sep 23, 2008·Expert Opinion on Pharmacotherapy·Harald Gollnick, Alison Layton
Feb 10, 2010·American Journal of Clinical Dermatology·Ali AlikhanSteven R Feldman
Apr 8, 2010·American Journal of Clinical Dermatology·Kate McKeage, Emma D Deeks

❮ Previous
Next ❯

Citations

Jul 11, 2012·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Matthew D ZuckermanChristopher D Rosenbaum
Sep 13, 2011·Annales de dermatologie et de vénéréologie·A ParodiR Gallo
May 26, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·A-H R JørgensenJ P Thyssen
Nov 22, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Maja A Hofmann, Percy Lehmann
Nov 22, 2016·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Maja A Hofmann, Percy Lehmann
Aug 29, 2017·Journal of the European Academy of Dermatology and Venereology : JEADV·G CiccareseF Drago
Aug 7, 2017·The Journal of Dermatology·Francesco DragoAurora Parodi
Jul 12, 2019·Dermatologic Therapy·Recep DursunKoray Durmaz
Oct 24, 2017·International Journal of Dermatology·Francesco DragoAurora Parodi
Feb 28, 2018·Giornale Italiano Di Dermatologia E Venereologia : Organo Ufficiale, Società Italiana Di Dermatologia E Sifilografia·Francesco DragoAurora Parodi
Mar 16, 2021·Dermatologic Therapy·Aslı Aksu Çermanİlknur Kıvanç Altunay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Acta Dermatovenerologica Alpina, Pannonica, Et Adriatica
Zorana DakovićMiloc D Pavlović
Clinical, Cosmetic and Investigational Dermatology
Sheila ValentínAbimael Rivera
Journal of the American Academy of Dermatology
S Sibenge, D J Gawkrodger
Seminars in Cutaneous Medicine and Surgery
Jason EmerDiane Berson
© 2021 Meta ULC. All rights reserved